Author Question: A client suffers from a genetic bleeding deficiency. What blood product will be administered? A) ... (Read 64 times)

Starlight

  • Hero Member
  • *****
  • Posts: 567
A client suffers from a genetic bleeding deficiency. What blood product will be administered?
 
  A) Whole blood
  B) Albumin
  C) Platelets
  D) Cryoprecipitate

Question 2

The laboratory calls the nurse to report the patient has a shift of the differential count to the left. The nurse knows this indicates the patient most likely suffers from
 
  A) Viral infection
  B) Bacterial infection
  C) Chickenpox
  D) Hepatitis



zhanghao

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

Ans: D

Answer to Question 2

Ans: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library